Nasdaq 100 Stocks SEC Filings — April 20, 2026

20-04-2026

Saga Communications, Inc. (SGA) filed Definitive Additional Proxy Materials (DEFA14A) on April 20, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No specific proposals, financial data, or other substantive details are included in the provided materials.

20-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed a Form 8-K on April 20, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Exhibits), announcing the issuance of a press release titled 'AITX Shares Fiscal 2027 Revenue Targets and Market Opportunity.' The press release is furnished as Exhibit 99.1. No specific financial figures, targets, or performance metrics were detailed in the filing itself.

20-04-2026

This DEF 14A proxy statement solicits votes for the Joint Annual Meeting of Shareholders of nine Virtus closed-end funds, including Virtus Artificial Intelligence & Technology Opportunities Fund (AIO), held virtually on June 1, 2026 at 3:30 p.m. ET. Proposals include electing multiple Class I, II, and III trustees/directors specific to each fund (e.g., Donald C. Burke, R. Keith Walton, and Brian T. Zino for AIO) and ratifying PricewaterhouseCoopers LLP as independent auditor for each fund. The Boards, including independent trustees, unanimously recommend voting 'FOR' all nominees and the ratification.

• ·Record date for shareholders entitled to vote: close of business on March 31, 2026
• ·Virtual meeting access: www.meetnow.global/MN6WL79 (control number from proxy card required)
• ·Proxy materials first mailed: on or about April 20, 2026
• ·Advance registration deadline for beneficial owners: 5:00 p.m. ET on May 27, 2026 (email legal proxy to shareholdermeetings@computershare.com)

20-04-2026

On April 17, 2026, Faraday Future Intelligent Electric Inc. entered into a Note Purchase Agreement with an accredited investor, issuing a Promissory Note A-1 with $15,780,000 principal and a Secured Promissory Note B with $30,000,000 principal for an aggregate purchase price of $45 million. The notes mature in 24 months, carry 9% and 3.5% interest rates respectively, and allow investor redemptions into Class A Common Stock after 6 months, subject to share reservations and Nasdaq minimum price rules. No period-over-period financial metrics are reported, but the agreement includes dilutive equity conversion risks and strict exchange conditions requiring at least $5 million shareholders' equity and market cap.

• ·Share Reserve to be established within 10 trading days after next annual stockholder meeting, calculated as 1.5x (A Notes balance / Nasdaq Minimum Price) + 0.5x (B Note balance / Nasdaq Minimum Price).
• ·Note Exchange right upon A Notes reduction by at least $300,000, up to half of reduction amount, subject to Exchange Conditions including stockholder approval.
• ·Redemptions start 6 months after Purchase Price Date; aggregated across A Notes with cash or equity payment options if Nasdaq Minimum Price >= $0.0603.
• ·Monitoring fee after 180 days: (Outstanding Balance / 0.80) - Outstanding Balance.
• ·Trigger Events lead to potential Event of Default and Mandatory Default Amount after Cure Period.

20-04-2026

Reading International, Inc. filed a 10-K/A on April 20, 2026, incorporating exhibits by reference from prior 10-K and 10-K/A filings for the years ended December 31, 2024 and 2025. Key exhibits include Insider Trading Policies (19.1 and 19.2), List of Subsidiaries (21), Consent from Grant Thornton LLP (23.1), Sarbanes-Oxley certifications (31.1, 31.2, 32.1, 32.2), and Executive Officer Clawback Policy (97.1). No new financial data or performance metrics are disclosed.

• ·Clawback Policy effective as of October 2, 2023.
• ·Exhibits reference 10-K/A No.1 for year ended December 31, 2024 (filed April 21, 2025) and 10-K for year ended December 31, 2025 (filed March 31, 2026).

20-04-2026

Immuneering Corporation (IMRX) filed a DEFA14A Definitive Additional Proxy Materials on April 20, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. This filing serves as soliciting material to supplement ongoing proxy efforts, with no fee required. No financial metrics, performance data, or operational updates are disclosed in the provided filing header.

• ·Filing Type: DEFA14A (Schedule 14A)
• ·Filed by the Registrant
• ·No fee required

20-04-2026

Entravision Communications Corporation's DEF 14A proxy statement, filed April 20, 2026, solicits votes for the virtual 2026 Annual Meeting on May 28, 2026, including electing seven directors, ratifying Deloitte & Touche LLP as independent auditors for FY 2026, advisory approval of named executive officer compensation, and amending the 2004 Equity Incentive Plan to authorize an additional 6,000,000 shares of Class A common stock. The record date is April 13, 2026, with 82,686,451 Class A shares outstanding entitled to vote. No financial performance metrics are detailed, focusing instead on standard governance proposals.

• ·Meeting held virtually only at 10:00 a.m. Pacific Daylight Time; no physical location.
• ·Quorum requires majority voting interest of Class A common stock.
• ·Brokers have discretionary voting authority only for auditor ratification (Proposal 2).

20-04-2026

Apple Inc. announced on April 17, 2026, that Tim Cook will transition from Chief Executive Officer to Executive Chair of the Board effective September 1, 2026. The Board appointed John Ternus, currently Senior Vice President of Hardware Engineering, as the new CEO and a Board member effective the same date, with Art Levinson transitioning from Chair to Lead Independent Director. There are no family relationships or disclosable transactions involving Mr. Ternus.

• ·Apple and Mr. Ternus will enter into the company's standard indemnification agreement for directors and executive officers.
• ·Apple intends to file an amendment to this 8-K with information required by Item 5.02(c)(3) within four business days after it becomes available.
• ·No family relationships between Mr. Ternus and any director or executive officer pursuant to Item 401(d) of Regulation S-K.
• ·No transactions between Mr. Ternus and Apple required to be disclosed pursuant to Item 404(a) of Regulation S-K.

20-04-2026

Acadia Realty Limited Partnership (Parent Borrower), along with Albee Retail Development LLC, Albee Development LLC, and Albee Phase 3 Development LLC (City Point Borrowers), entered into a Fourth Amended and Restated Credit Agreement dated April 17, 2026, restating the prior Third Amended and Restated Credit Agreement from April 15, 2024, with Acadia Realty Trust and certain subsidiaries as guarantors. The agreement establishes a Revolving Credit Facility, Term A-1 Facility, Term A-2 Facility, and Term A-3 Facility, administered by Bank of America, N.A., with participation from multiple banks including Wells Fargo, M&T, Truist, and PNC as syndication agents. No specific facility sizes or commitment amounts are detailed in the provided filing excerpt, and no declines or flat performance metrics are mentioned.

• ·Published Deal CUSIP Number: 00423GAN3
• ·Published Revolver CUSIP Number: 00423GAP8
• ·Published Term A-1 CUSIP Number: 00423GAQ6
• ·Published Term A-2 CUSIP Number: 00423GAR4
• ·Published Term A-3 CUSIP Number: 00423GAS2
• ·Existing Credit Agreement dated April 15, 2024

20-04-2026

Intelligent Bio Solutions Inc. (INBS) furnished an investor presentation under Item 7.01 (Regulation FD Disclosure) on April 20, 2026, accessible via the Investors section of www.ibs.inc. Under Item 8.01, the company updated shares outstanding to 2,176,848 common shares as of April 20, 2026, following warrant exercises and sales under the September 18, 2024 ATM Offering Agreement with Ladenburg Thalmann & Co. Inc. No financial performance metrics, period comparisons, or other quantitative business updates were provided in the filing.

• ·ATM Offering Agreement dated September 18, 2024
• ·Previous 8-K filed March 23, 2026
• ·Presentation as Exhibit 99.1

20-04-2026

Muncy Columbia Financial Corporation reported Q1 2026 net income of $7,156,000 ($2.02 per share), up 64.6% YoY from $4,345,000 ($1.23 per share), driven by net interest income growth of 18.6% to $16,443,000 and a fully tax-equivalent net interest margin expansion to 4.33% from 3.83%. Non-interest income rose slightly to $2,490,000 despite a $637,000 loss on loan sales (vs. $83,000 gain YoY), while non-interest expense fell 9.1% to $10,197,000 due to lower salaries after prior-year one-time costs. Total assets grew to $1,717,328,000 with strong deposit growth of $40,816,000 QoQ, though book value per share dipped slightly to $54.29 from $54.44 QoQ.

• ·Provision for credit losses $69,000 in Q1 2026 vs. $110,000 in Q1 2025.
• ·Special one-time cash dividend of $1.00 per share declared Feb 18, 2026, payable Apr 23, 2026.
• ·Sales tax refund of $454,000 received in Q1 2026.
• ·Journey Bank Common equity tier 1 capital ratio 15.87% at Mar 31, 2026.

20-04-2026

On April 15, 2026, the Board of Trustees of abrdn National Municipal Income Fund (VFL) approved a change to its non-fundamental investment policy, increasing the limit on below-investment grade municipal obligations from 20% of net assets to 100% of assets, effective June 1, 2026. This Supplement No. 1, dated April 20, 2026, updates the Joint Proxy Statement/Prospectus dated March 11, 2026, by removing or replacing descriptions of the prior 20% limitation and aligning VFL's strategy with MFS Municipal Income Trust. No financial metrics or performance data are provided.

• ·This change eliminates certain described differences between VFL and MFS Municipal Income Trust in the Proxy/Prospectus sections on principal investment strategies and risks.
• ·The Supplement must be read in conjunction with the original Proxy/Prospectus and supersedes inconsistent information.